Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
50 Leser
Artikel bewerten:
(0)

Research and Markets - Global Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast 2015-2021 Featuring Roche Diagnostic, LifeScan, Bayer HealthCare & Abbott Laboratories

DUBLIN, September 15, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global - Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast" report to their offering.

Global Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast report analyses the Country Wise Diabetes Population, Country Wise SMBG Users and Market, Company Wise SMBG Revenue and the driving factors and challenges for the SMBG market.

Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. Self-monitoring of blood glucose is a very lucrative business with enormous market opportunity.

The primary growth factors for the SMBG market is the increasing global diabetic population; increasing awareness among the diabetes population, increasing spending on healthcare, active reimbursement policies and the technological advancement aimed at minimal and non-invasive testing methods.

Key Highlights:

  • United States, Russia and United Kingdom are the top three leading countries in the Global SMBG market.
  • China is at the fourth spot being closely followed by Italy
  • China dominates the self-monitoring of blood glucose users
  • Test Strips account for maximum share of the SMBG market.
  • Blood glucose test strips market is mainly dominated by developed countries.
  • Blood glucose meter is the second leading product segment while lancet captures the least share of the SMBG market.
  • In 2014, Life Scan became the leading player in SMBG market.

The SMBG Market covered in the report is analyzed from 4 viewpoints follows:

1. Country Wise Diabetes Population and Forecast (2007 - 2021) I. Type 1 Diabetes Population II. Type 2 Diabetes Population

2. Country Wise SMBG Users and Forecast (2007 - 2021)

3. Country Wise SMBG Market and Forecast (2007 - 2021)

I. Blood Glucose Test Strips Market

II. Blood Glucose Lancet Market

III. Blood Glucose Meter Market

4. Company Wise SMBG Revenue and Forecast (2007 - 2021)

The 18 Countries analyzed in the reports are as follows:

1. United States

2. Brazil

3. United Kingdom

4. Germany

5. Spain

6. Italy

7. Netherlands

8. Norway

9. Sweden

10. Switzerland

11. Russia

12. India

13. China

14. Thailand

15. Korea

16. Malaysia

17. Australia

18. Kuwait

The 4 Companies analyzed in the reports are as follows:

1. Roche Diagnostic

2. LifeScan Inc

3. Bayer HealthCare

4. Abbott Laboratories

For more information about this report visit http://www.researchandmarkets.com/research/smzq3v/global_self

Related Topics: Home Testing and Home Healthcare, Diabetes Devices

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.